Chang Carmen
Insider CIK 1746342 · MRKR 10% owner · SVRA 10% owner · GNCA 10% owner · RGLS 10% owner · TRVI 10% owner · MTCR 10% owner · COUR Director · BHG Director, 10% owner · KRRO 10% owner · AKUS 10% owner · MIRM 10% owner · MBX 10% owner · SGP 10% owner · GLUE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| COUR Coursera, Inc. | A Award | 2026-06-11 | 2026-06-15 | 34,260 | — | $0 | 122,520 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy deriv | 2026-03-10 | 2026-03-12 | 242,945 | $11.11 | $2.70M | 242,945 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-03-10 | 2026-03-12 | 207,100 | $11.11 | $2.30M | 1,297,893 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 402,273 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 954,990 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 1,619,240 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 2,989,408 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 954,990 | — | $0 | 954,990 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 5,097,538 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 937,500 | $16.00 | $15.00M | 6,035,038 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 402,273 | — | $0 | 1,357,263 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 4,359,576 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 75,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 125,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 124,085 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 607,536 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 1,656,789 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 37,700 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 186,128 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 372,255 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 186,128 | $0.01 | $1.9K | 674,830 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 1,159,683 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 551 | $6.75 | $3.7K | 1,159,683 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 372,255 | $0.01 | $3.7K | 1,160,234 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 787,979 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 788,259 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 2,384,873 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 182 | $6.75 | $1.2K | 2,384,873 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 124,085 | $0.01 | $1.2K | 2,385,055 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 900 | $6.75 | $6.1K | 2,260,970 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 607,536 | $0.01 | $6.1K | 2,261,870 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 2,455 | $6.75 | $16.6K | 1,654,334 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 1,656,789 | $0.01 | $16.6K | 1,656,789 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 674,554 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 276 | $6.75 | $1.9K | 674,554 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 488,982 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 488,702 | SEC↗ |
| COUR Coursera, Inc. | A Award | 2025-05-21 | 2025-05-23 | 21,765 | — | $0 | 88,260 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2024-12-23 | 2024-12-23 | 554,250 | $3.20 | $1.77M | 1,625,678 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 185,595 | — | $0 | 556,782 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| COUR Coursera, Inc. | A Award | 2024-05-22 | 2024-05-24 | 18,669 | — | $0 | 66,495 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2024-04-22 | 2024-04-24 | 17,857 | $56.00 | $1000.0K | 1,090,793 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 371,187 | — | $0 | 371,187 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-12-19 | 2023-12-21 | 175,525 | — | $0 | 1,656,789 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-10-31 | 2023-11-02 | 100,606 | — | $0 | 1,481,264 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-09-15 | 2023-09-19 | 552,263 | — | $0 | 1,380,658 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-08-11 | 2023-08-15 | 828,395 | — | $0 | 828,395 | SEC↗ |
| SVRA Savara Inc | P Buy | 2023-07-17 | 2023-07-19 | 333,333 | $3.00 | $1000.0K | 24,471,264 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 30,000 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 2,000,000 | — | $0 | 2,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 135 | — | $0 | 135 | SEC↗ |
| COUR Coursera, Inc. | A Award | 2023-05-24 | 2023-05-26 | 16,186 | — | $0 | 47,826 | SEC↗ |
| COUR Coursera, Inc. | S Sale | 2023-03-15 | 2023-03-17 | 1,226 | $11.82 | $14.5K | 31,640 | SEC↗ |
| COUR Coursera, Inc. | J Other | 2023-02-15 | 2023-02-17 | 1,226 | — | $0 | 32,866 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 4,294,207 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 100,000 | $1000.00 | $100.00M | 100,000 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 37,700 | $1000.00 | $37.70M | 37,700 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| COUR Coursera, Inc. | A Award | 2022-05-13 | 2022-05-16 | 8,655 | — | $0 | 31,640 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2022-04-11 | 2022-04-13 | 3,000,000 | $1.90 | $5.70M | 3,000,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 2,631,578 | $1.90 | $5.00M | 10,421,428 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 948,948 | $1.90 | $1.80M | 948,948 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-01-03 | 2022-01-05 | 125,000 | $1000.00 | $125.00M | 125,000 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-01-03 | 2022-01-05 | 75,000 | $1000.00 | $75.00M | 75,000 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 288,768 | $1.00 | $288.8K | 2,734,189 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 170,932 | $0.91 | $155.5K | 2,563,257 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-10 | 2021-12-27 | 37,570 | $1.32 | $49.6K | 3,022,957 | SEC↗ |
| COUR Coursera, Inc. | A Award | 2021-11-01 | 2021-11-03 | 22,985 | — | $0 | 22,985 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 7,789,850 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 9,588,725 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 11,500,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,361,912 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,954,906 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 12,712,399 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,448,856 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,224,428 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 4,980,687 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 1,050,000 | $19.00 | $19.95M | 7,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,715,968 | — | $0 | 2,715,968 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 3,257,328 | — | $0 | 5,973,296 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 669,002 | — | $0 | 6,642,298 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 5,864,718 | — | $0 | 5,864,718 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 38,137,197 | — | $0 | 44,001,915 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,673,284 | — | $0 | 47,675,199 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 250,000 | $18.00 | $4.50M | 47,925,199 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 14,942,061 | — | $0 | 14,942,061 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 7,346,568 | — | $0 | 22,288,629 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 1,694,444 | $18.00 | $30.50M | 23,983,073 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 258,707 | $6.22 | $1.61M | 258,707 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 5,239,254 | $0.13 | $681.1K | 5,239,254 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2020-12-04 | 2020-12-07 | 4,398,602 | $0.62 | $2.73M | 6,451,056 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 2,291,297 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 769,230 | $13.00 | $10.00M | 3,060,527 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 1,958,333 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 588,235 | $17.00 | $10.00M | 4,294,207 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 3,705,972 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 2,505,996 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 513,758 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise deriv | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2020-04-03 | 2020-04-13 | 564 | $2.66 | $1.5K | 5,937,998 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 5,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 9,009,000 | $0.13 | $1.17M | 9,009,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 900,900 | $6.66 | $6.00M | 900,900 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 29,889,945 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 4,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,736,243 | — | $0 | 3,736,243 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 17,099,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,500,000 | $10.00 | $15.00M | 4,438,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 1,938,562 | — | $0 | 1,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,000,000 | $10.00 | $10.00M | 2,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 3,703,704 | $0.13 | $481.5K | 3,703,704 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 256,700 | $10.80 | $2.77M | 256,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-09 | 1,136,704 | $1.08 | $1.23M | 2,052,454 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |